Pregled bibliografske jedinice broj: 575557
Serial Interferon-gammma Release Assay in Children With Latent Tuberculosis Infection and Children With Tuberculosis
Serial Interferon-gammma Release Assay in Children With Latent Tuberculosis Infection and Children With Tuberculosis // Pediatric pulmonology, 47 (2012), 4; 401-408 doi:10.1002/ppul.21555 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 575557 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Serial Interferon-gammma Release Assay in Children With Latent Tuberculosis Infection and Children With Tuberculosis
(Serial Interferon-gamma Release Assay in Children With Latent Tuberculosis Infection and Children With Tuberculosis)
Autori
Nenadić, Nataša ; Kristić Kirin, Branka ; Zoričić Letoja, Ivka ; Plavec, Davor ; Zrinski Topić, Renata ; Dodig, Slavica
Izvornik
Pediatric pulmonology (8755-6863) 47
(2012), 4;
401-408
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
children; interferon-gamma release assay; latent tuberculosis infection
Sažetak
Interferon-γ (IFN-γ) release assay (IGRA) is used for diagnosis of latent tuberculosis infection (LTBI), and for serial testing of active tuberculosis (TB). The aim of this study was to evaluate the results of IGRA for diagnosis and treatment monitoring of children with LTBI and children with TB. IGRA was performed in BCG vaccinated children before and six months after the beginning of treatment. A total of 59 BCG vaccinated children aged 4-18 years were investigated due to exposure to active TB. The participants were divided into two groups: Group 1, children with LTBI (N = 41), and Group 2, children with TB (N = 18). IGRA (QuantiFERON-TB Gold In-Tube) was performed twice, i.e., before treatment and at the end of prophylaxis and therapy. There was no significant difference in IFN-γ concentrations between Group 1 and Group 2 subjects either before or after the treatment. Difference between pre-treatment and post-treatment IFN-γ concentrations compared in either Group 1 or Group 2 was not statistically significant. During follow-up, children with LTBI did not develop active TB. In addition, in children with TB, signs and symptoms of TB improved with anti-TB therapy. This study showed that the concentrations of IFN-γ did not differ in children with LTBI and TB either before or at the end of treatment. IGRA may remain positive over a long period of time. It seems that IGRA is not useful for monitoring treatment of children with LTBI and children with TB. Pediatr Pulmonol.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Projekti:
277-0000000-3436 - Usporedba učinaka dva načina vođenja terapije astme u djece 12-18 godina (Plavec, Davor, MZOS ) ( CroRIS)
277-2770966-0965 - Kondenzat izdaha kao izvor biomarkera plućnih bolesti u djece (Dodig, Slavica, MZOS ) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Dječja bolnica Srebrnjak
Profili:
Nataša Nenadić
(autor)
Ivka Zoričić-Letoja
(autor)
Slavica Dodig
(autor)
Davor Plavec
(autor)
Renata Zrinski Topić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- EMBASE (Excerpta Medica)
- MEDLINE
- Clinical Medicine